DEA Actions – Further Clarification
Blue Moon Hemp – DEA Ruling – Further Legal Clarification December 16, 2016 Today, many of you have forwarded us stories that are sweeping our industry regarding the DEA reclassifying CBD as a Schedule I Drug. To follow is our response to those stories, and the DEA’s actions: Fundamentally, CBD derived from hemp is not specifically […]